1 day Ago By ABMN Staff
Clearmind Medicine Inc. ( NASDAQ:CMND – Get Free Report ) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 245,800 shares, a growth of 10.
2% from the August 15th total of 223,100 shares. Based on an average trading volume of 1,950,000 shares, the short-interest ratio is presently 0.1 days.
Currently, 8.3% of the company’s shares are short sold. Clearmind Medicine Stock Down 1.
5 % Shares of NASDAQ:CMND traded down $0.02 on Wednesday, hitting $1.32.
60,302 shares of the company’s stock were exchanged, compared to its average volume of 1,591,921. Clearmind Medicine has a 12 month low of $0.92 and a 12 month high of $10.
35. The business’s 50 day simple moving average is $1.43 and its two-hundred day simple moving average is $1.
32. Institutional Investors Weigh In On Clearmind Medicine A hedge fund recently bought a new stake in Clearmind Medicine stock. Cornerstone Wealth Group LLC bought a new position in shares of Clearmind Medicine Inc.
( NASDAQ:CMND – Free Report ) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 20,000 shares of the company’s stock, valued at approximately $34,000. Cornerstone Wealth Group LLC owned 1.
18% of Clearmind Medicine as of its most recent filing with the Securities and Exchange Commission (SEC). 96.05% of the stock is owned by institutional investors and hedge funds.
About Clearmind Medicine Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors. Featured Articles Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.
com's FREE daily email newsletter ..
